S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,419.04 -0.58%
Next Bullish Trade
Sign in
IMUX

Immunic, Inc. NCM · IMUX

$15.16 +0.13 (+0.86%)
Neutral · +0.49σ
+ Compare Open in Sniper

Valuation

Market cap $0.2B
P/E (ttm) —
Forward P/E -4.3
Beta (5y) 1.38
Shares out 13.6M
Div yield —

Profitability & returns

ROE -142.9%
Net margin —
FCF margin —
Debt / equity 0.00

Trading information

Last price $15.16
Day range $14.60 – $15.84
52-wk range $5.73 – $15.84
Avg volume 0.3M
RSI (2) 83.3
Trend zone Neutral
52-week range · today's price
$5.73$15.84

Company

Sector Healthcare
Industry Biotechnology
Exchange NCM
Next earnings 2026-08-06

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company…